Part II: Targeting SARS-COV2
Thanks for this. Preventative and early treatment works, but until it's an Rx the medical community is not interested.
Flccc has done great work in this area. I have been on their protocol all year and, in spite of close exposures, have not gotten ill when others in the group did.
I'd hesitate to use the FLCCC as a source for legitimizing the use of ivermectin in clinical practice. First, the dose they recommend is much different than the "safe" evaluated dose for parasitic infections that was approved by the FDA log ago; thus the potential physiologic effects are not known and the relative safety of the drug given at their recommendation cannot be extrapolated from the existing data. Additionally, I would hesitate to take any sort of guidance from a group for whom "membership" requires that you support their recommendations (their "join us" form asks that the applicant check off all the drugs that they use in practice, which is basically a list of the vitamins/drugs the FLCCC recommends). Does ivermectin work theoretically? Sure, there's evidence. Does it work in actual clinical settings? The verdict is still not clear, mostly being anecdotal or small scale. Given the lack of large scale controlled clinical trials (and lack of dose-escalation studies to even define a working range), it seems premature to advocate for their inclusion in a treatment regimen - especially for prophylaxis.